Skip to main content

Table 3 Summary of trials which investigated treatment outcome

From: A systematic review of community based hepatitis C treatment

Study

Facility

N

Age (years)

Gender (% male)

Genotype 1 (%)

HIV infected n (%)

Prior treatment

Fibrosis assessment

Fibrosis result

SVR

Mean or %

n (%)

Arora

Tertiary

146

45

45

57

0

Naive

APRI

0.938

84 (58)

Telehealth

261

42

73

56

0

0.935

152 (58)

Bruce

Tertiary

9

43

67

67 (G1&4)

3 (33)

N/P

Biopsy (G1 only)

F4 33 %

1 (33)

Primary

12

40

42

67 (G1&4)

3 (25)

F4 25 %

6 (75)

Chen

Tertiary

150

52

N/P

58

0

Naive

 

N/P

99 (66)

Primary

148

47

N/P

61

0

N/P

102 (69)

Jou

Academic

1905

48

59

100

0

Naive

Biopsy

F3/4 10 %

760 (40)

Community

1165

47

61

100

0

F3/4 11 %

455 (39)

Kuo

Preintervention

18

57

33

N/P

N/P

N/P

 

N/P

2 (50)

Post intervention

3 (100)

Myers

Academic

133

46

70

49

0

Naïve & experienced

Biopsy

F4 14 %

79 (59)

Community

250

46

64

55

0

F4 10 %

120 (48)

Nazareth

Tertiary

528

43

65

N/P

N/P

Naïve & experienced

Biopsy or Hepascore

F4 19 %

311 (59)

Telehealth

50

46

50

60

N/P

Hepascore

F4 20 %

36 (72)

Niedaerau

Hospital based

621

N/P

N/P

100

N/P

N/P

 

N/P

290 (47)

Private practice

3778

N/P

N/P

100

N/P

N/P

1744 (46)

Rossaro

Tertiary

40

54

55

65

0

Naive

Biopsy

F4 45 %

16 (43)

Telehealth

40

51

48

65

0

F4 28 %

21 (55)

  1. N/P not provided